[1] |
刘凤荣. 孵化中臭蛋的产生及处理[J]. 中国禽业导刊, 1998, 14(2):11.LIU F R. Production and treatment of rotten eggs during incubation[J]. China Poultry Industry Guide, 1998, 14(2):11. (in Chinese)
|
[2] |
鲍文龙, 李德福. 臭蛋在孵化室中的危害及预防方法[J]. 养禽与禽病防治, 1997(12):15.BAO W L, LI D F. The harm of rotten eggs in hatching chamber and prevention methods[J]. Poultry Husbandry and Disease Control, 1997(12):15. (in Chinese)
|
[3] |
杨景满. 种蛋孵化过程中臭蛋产生的原因及防制[J]. 中国家禽, 2000, 22(7):42.YANG J M. Causes and control of rotten eggs during hatching of breeding eggs[J]. China Poultry, 2000, 22(7):42. (in Chinese)
|
[4] |
HARPER D R, ENRIGHT M C. Bacteriophages for the treatment of Pseudomonas aeruginosa infections[J]. J Appl Microbiol, 2011, 111(1):1-7.
|
[5] |
魏光. 铜绿假单胞菌耐药性分析及碳青霉烯类耐药铜绿假单胞菌外排泵MexAB-OprM的相关研究[D]. 合肥:安徽医科大学, 2014.WEI G. Analysis of antibiotics resistance among Pseudomonas aeruginosa and correlated study on efflux pump MexAB-OprM in carbapenem-resistant Pseudomonas aeruginosa[D]. Hefei:Anhui Medical University, 2014. (in Chinese)
|
[6] |
周小青. 铜绿假单胞菌的耐药情况及基因同源性分析[D]. 南宁:广西医科大学, 2014.ZHOU X Q. Analysis of drug resistance and gene homology of Pseudomonas aeruginosa[D]. Nanning:Guangxi Medical University, 2014. (in Chinese)
|
[7] |
陈龙, 胡佳萍, 徐文刚, 等. 噬菌体治疗铜绿假单胞菌感染的初步应用研究[J]. 中国卫生检验杂志, 2016, 26(10):1409-1411.CHEN L, HU J P, XU W G, et al. Preliminary application of bacteriophages against Pseudomonas aeruginosa infection[J]. Chinese Journal of Health Laboratory Technology, 2016, 26(10):1409-1411. (in Chinese)
|
[8] |
OFIR G, SOREK R. Contemporary phage biology:from classic models to new insights[J]. Cell, 2018, 172(6):1260-1270.
|
[9] |
ABEDON S T, THOMAS-ABEDON C. Phage therapy pharmacology[J]. Curr Pharm Biotechnol, 2010, 11(1):28-47.
|
[10] |
毛普加, 曾韦锟, 洪愉, 等. 宿主菌抗噬菌体机制的研究进展[J]. 病毒学报, 2015, 31(4):474-479.MAO P J, ZENG W K, HONG Y, et al. Advances of researches on anti-phage mechanisms of host[J]. Chinese Journal of Virology, 2015, 31(4):474-479. (in Chinese)
|
[11] |
CHAN B K, ABEDON S T. Phage therapy pharmacology:phage cocktails[J]. Adv Appl Microbiol, 2012, 78:1-23.
|
[12] |
ABEDON S T. Phage therapy pharmacology:calculating phage dosing[J]. Adv Appl Microbiol, 2011, 77:1-40.
|
[13] |
NILSSON A S. Phage therapy-constraints and possibilities[J]. Upsala J Med Sci, 2014, 119(2):192-198.
|
[14] |
CHATURONGAKUL S, OUNJAI P. Phage-host interplay:examples from tailed phages and Gram-negative bacterial pathogens[J]. Front Microbiol, 2014, 5:442.
|
[15] |
REHMAN S, ALI Z, KHAN M, et al. The dawn of phage therapy[J]. Rev Med Virol, 2019, 29(4):e2041.
|
[16] |
JOŃCZYK-MATYSIAK E, ŁODEJ N, KULA D, et al. Factors determining phage stability/activity:challenges in practical phage application[J]. Exp Rev Anti-infective Ther, 2019, 17(8):583-606.
|
[17] |
RYAN E M, GORMAN S P, DONNELLY R F, et al. Recent advances in bacteriophage therapy:how delivery routes, formulation, concentration and timing influence the success of phage therapy[J]. J Pharm Pharmacol, 2011, 63(10):1253-1264.
|
[18] |
KORTRIGHT K E, CHAN B K, KOFF J L, et al. Phage therapy:a renewed approach to combat antibiotic-resistant bacteria[J]. Cell Host Microbe, 2019, 25(2):219-232.
|
[19] |
RYLOV V N. Bacteriophages of Pseudomonas aeruginosa:long-term prospects for use in phage therapy[J]. Adv Virus Res, 2014, 88:227-278.
|
[20] |
VIERTEL T M, RITTER K, HORZ H P. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens[J]. J Antimicrob Chemother, 2014, 69(9):2326-2336.
|
[21] |
REINA J, REINA N. Phage therapy, an alternative to antibiotic therapy?[J]. Rev Esp Quimioter, 2018, 31(2):101-104.
|
[22] |
JAMALLUDEEN N, JOHNSON R P, FRIENDSHIP R, et al. Isolation and characterization of nine bacteriophages that lyse O149 enterotoxigenic Escherichia coli[J]. Vet Microbiol, 2007, 124(1-2):47-57.
|
[23] |
王杰, 李璐璐, 张庆. 噬菌体RZⅢ-3的生物学特性分析及对鸡大肠杆菌的疗效[J]. 畜牧兽医学报, 2017, 48(11):2166-2172.WANG J, LI L L, ZHANG Q. Biological characteristics analysis of phage RZⅢ-3 to Escherichia coli and the therapeutic effect on chicken[J]. Acta Veterinaria et Zootechnica Sinica, 2017, 48(11):2166-2172. (in Chinese)
|
[24] |
商延. 抗药性沙门氏菌及其噬菌体的相互作用关系[D]. 济南:山东大学, 2018.SHANG Y. Interaction relationship between antimicrobial-resistant Salmonella and their phages[D]. Ji'nan:Shandong University, 2018. (in Chinese)
|
[25] |
JIANG Y H, LIU J Q, ZHAO C Y, et al. Isolation and genome sequencing of a novel Pseudomonas aeruginosa phage PA-YS35[J]. Curr Microbiol, 2020, 77(1):123-128, doi:10. 1007/s00284-019-01792-8.
|
[26] |
YU S, HUANG H L, HAO Y C, et al. Complete genome sequence of the Myoviral bacteriophage YS35, which causes the lysis of a multidrug-resistant Pseudomonas aeruginosa strain[J]. Genome Announc, 2018, 6(6):e01395-17.
|
[27] |
BORYSOWSKI J, MIEDZYBRODZKI R, GÓRSKI A. 噬菌体治疗-当前的研究和应用[M]. 王冉, 刘玉庆, 译. 北京:化学工业出版社, 2019.BORYSOWSKI J, MIEDZYBRODZKI R, GORSKI A. Phage therapy-current research and applications[M]. WANG R, LIU Y Q, trans. Beijing:Chemical Industry Press, 2019. (in Chinese)
|
[28] |
GOLKAR Z, BAGASRA O, JAMIL N. Experimental phage therapy on multiple drug resistant Pseudomonas aeruginosa infection in mice[J/OL]. J Antivir Antiretrovir, 2013, S10(6):S10-005.[2020-04-30] . https://www.longdom.org/open-access/experimental-phage-therapy-on-multiple-drug-resistant-pseudomonas-aeruginosa-infection-in-mice-jaa.S10-005.pdf.
|
[29] |
MCVAY C S, VELÁSQUEZ M, FRALICK J A. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model[J]. Antimicrob Agents Chemother, 2007, 51(6):1934-1938.
|
[30] |
KHAIRNAR K, RAUT M P, CHANDEKAR R H, et al. Novel bacteriophage therapy for controlling metallo-beta-lactamase producing Pseudomonas aeruginosa infection in catfish[J]. BMC Vet Res, 2013, 9(1):264.
|
[31] |
MARZA J A S, SOOTHILL J S, BOYDELL P, et al. Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients[J]. Burns, 2006, 32(5):644-646.
|
[32] |
WRIGHT A, HAWKINS C H, ÄNGGÅRD E E, et al. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant; a preliminary report of efficacy[J]. Clin Otolaryngol, 2009, 34(4):349-357.
|
[33] |
XIE H J, ZHUANG X L, KONG J, et al. Bacteriophage Esc-A is an efficient therapy for Escherichia COLI 3-1 caused diarrhea in chickens[J]. Gen Appl Microbiol, 2005, 51(3):159-163.
|
[34] |
HUFF W E, HUFF G R, RATH N C, et al. Therapeutic efficacy of bacteriophage and Baytril (enrofloxacin) individually and in combination to treat colibacillosis in broilers[J]. Poult Sci, 2004, 83(12):1944-1947.
|